Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 16.00 TWD
Change Today +0.05 / 0.31%
Volume 29.1K
4117 On Other Exchanges
As of 11:30 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

general biologicals corp (4117) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/22/14 - 35.65
52 Week Low
06/23/15 - 14.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GENERAL BIOLOGICALS CORP (4117)

Related News

No related news articles were found.

general biologicals corp (4117) Related Businessweek News

No Related Businessweek News Found

general biologicals corp (4117) Details

General Biologicals Corporation manufactures in-vitro diagnostic devices in Taiwan and internationally. The company provides various diagnostic products, including raw materials for antibody and antigen; radioimmunoassay devices for quantitative determination of hepatitis, gastrin, thyroid, and vitamin; and enzyme-linked immunoassay devices for hepatitis, retrovirus, thyroid, fertility, tumor markers, infectious diseases, steroids, and others. It also offers point-of-care test, real-time polymerase chain reaction, rapid test, labware, and oasys devices. In addition, the company provides BioFibroScore, a non-invasive liver fibrosis platform; private label/ODM services to various companies; and build-operate-transfer services for hospitals and clinics, as well as personnel hiring, training, imaging system lending, and technology developments services. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu, Taiwan.

Founded in 1984

general biologicals corp (4117) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

general biologicals corp (4117) Key Developments

General Biologicals Corporation, Annual General Meeting, Jun 29, 2015

General Biologicals Corporation, Annual General Meeting, Jun 29, 2015.

General Biologicals Corporation, Annual General Meeting, Jun 23, 2014

General Biologicals Corporation, Annual General Meeting, Jun 23, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4117:TT 16.00 TWD +0.05

4117 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4117.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4117 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENERAL BIOLOGICALS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at